Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss- based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules’ transformation into a science-
Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. Senn develops and manufactures, Peptides and Peptides based applications for its global customers, providing contract research, development, and manufacturing services.
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
